These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11246664)

  • 1. Lack of relationship between functional ability and skin score in patients with systemic sclerosis.
    Herrick A; Rooney B; Finn J; Silman A
    J Rheumatol; 2001 Feb; 28(2):292-5. PubMed ID: 11246664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
    Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Seibold JR
    Arthritis Rheum; 2001 Mar; 44(3):653-61. PubMed ID: 11263780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.
    Pope JE; Bellamy N; Seibold JR; Baron M; Ellman M; Carette S; Smith CD; Chalmers IM; Hong P; O'Hanlon D; Kaminska E; Markland J; Sibley J; Catoggio L; Furst DE
    Arthritis Rheum; 2001 Jun; 44(6):1351-8. PubMed ID: 11407694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis.
    Clements PJ; Wong WK; Hurwitz EL; Furst DE; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen V; Martin R; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold J
    Arthritis Rheum; 1999 Nov; 42(11):2372-80. PubMed ID: 10555033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using a self-reported functional score to assess disease progression in systemic sclerosis.
    Serednicka K; Smyth AE; Black CM; Denton CP
    Rheumatology (Oxford); 2007 Jul; 46(7):1107-10. PubMed ID: 17426141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a manual ability questionnaire in patients with systemic sclerosis.
    Vanthuyne M; Smith V; Arat S; Westhovens R; de Keyser F; Houssiau FA; Thonnard JL; Vandervelde L
    Arthritis Rheum; 2009 May; 61(5):695-703. PubMed ID: 19405012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis.
    Furst DE; Clements PJ; Steen VD; Medsger TA; Masi AT; D'Angelo WA; Lachenbruch PA; Grau RG; Seibold JR
    J Rheumatol; 1998 Jan; 25(1):84-8. PubMed ID: 9458208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis.
    Kuwana M; Sato S; Kikuchi K; Kawaguchi Y; Fujisaku A; Misaki Y; Hatamochi A; Kondo H; Takehara K
    J Rheumatol; 2003 Jun; 30(6):1253-8. PubMed ID: 12784399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases.
    Johnson SR; Glaman DD; Schentag CT; Lee P
    J Rheumatol; 2006 Jun; 33(6):1117-22. PubMed ID: 16622903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.
    Clements PJ; Hurwitz EL; Wong WK; Seibold JR; Mayes M; White B; Wigley F; Weisman M; Barr W; Moreland L; Medsger TA; Steen VD; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Furst DE
    Arthritis Rheum; 2000 Nov; 43(11):2445-54. PubMed ID: 11083267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular late potentials in systemic sclerosis: relationship with skin involvement.
    Paradiso M; Di Franco M; Musca A; Basili S; Riccieri V; Paoletti V; De Matteis A; Mammarella A
    J Rheumatol; 2002 Jul; 29(7):1388-92. PubMed ID: 12136893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
    Khanna D; Furst DE; Clements PJ; Park GS; Hays RD; Yoon J; Korn JH; Merkel PA; Rothfield N; Wigley FM; Moreland LW; Silver R; Steen VD; Weisman M; Mayes MD; Collier DH; Medsger TA; Seibold JR; ;
    J Rheumatol; 2005 May; 32(5):832-40. PubMed ID: 15868618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of hardness, elasticity and viscosity of the skin of patients with systemic sclerosis using a novel sensing device (Vesmeter): a proposal for a new outcome measurement procedure.
    Kuwahara Y; Shima Y; Shirayama D; Kawai M; Hagihara K; Hirano T; Arimitsu J; Ogata A; Tanaka T; Kawase I
    Rheumatology (Oxford); 2008 Jul; 47(7):1018-24. PubMed ID: 18440998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud's phenomenon and systemic sclerosis: a randomized, open, single-center study.
    Kawald A; Burmester GR; Huscher D; Sunderkötter C; Riemekasten G
    J Rheumatol; 2008 Sep; 35(9):1830-7. PubMed ID: 18634152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durometry for the assessment of skin disease in systemic sclerosis.
    Kissin EY; Schiller AM; Gelbard RB; Anderson JJ; Falanga V; Simms RW; Korn JH; Merkel PA
    Arthritis Rheum; 2006 Aug; 55(4):603-9. PubMed ID: 16874783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hand vascular involvement assessed by magnetic resonance angiography in systemic sclerosis.
    Allanore Y; Seror R; Chevrot A; Kahan A; Drapé JL
    Arthritis Rheum; 2007 Aug; 56(8):2747-54. PubMed ID: 17665441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.
    Clements P; Lachenbruch P; Siebold J; White B; Weiner S; Martin R; Weinstein A; Weisman M; Mayes M; Collier D
    J Rheumatol; 1995 Jul; 22(7):1281-5. PubMed ID: 7562759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model.
    Shand L; Lunt M; Nihtyanova S; Hoseini M; Silman A; Black CM; Denton CP
    Arthritis Rheum; 2007 Jul; 56(7):2422-31. PubMed ID: 17599771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.